FIA determination of pyruvate in serum based on direct chemiluminescence oxidation

Chemiluminescence was observed by mixing acidic potassium permanganate solution with pyruvate in the presence of quinine. A new simplified method for pyruvate determination based on this phenomenon was established. The chemiluminescence intensity is a linear function of the concentration of pyruvate in the range of 2 × 10^–6 to 1 × 10^–3 g/mL with a detection limit of 0.8 μg/mL and a relative standard deviation of less than 2.3%. The method has been successfully used to determine pyruvate in serum. Received: 3 April 1998 / Revised: 20 July 1998 / Accepted: 17 September 1998     

Determination of cyanide in blood by electrospray ionization tandem mass spectrometry after direct injection of dicyanogold

An electrospray ionization tandem mass spectrometric (ESI-MS-MS) method has been developed for the determination of cyanide (CN^–) in blood. Five microliters of blood was hemolyzed with 50 μL of water, then 5 μL of 1 M tetramethylammonium hydroxide solution was added to raise the pH of the hemolysate and to liberate CN^– from methemoglobin. CN^– was then reacted with NaAuCl₄ to produce dicyanogold, Au(CN)₂^–, that was extracted with 75 μL of methyl isobutyl ketone. Ten microliters of the extract was injected directly into an ESI-MS-MS instrument and quantification of CN^– was performed by selected reaction monitoring of the product ion CN^– at m/z 26, derived from the precursor ion Au(CN)₂^– at m/z 249. CN^– could be measured in the quantification range of 2.60 to 260 μg/L with the limit of detection at 0.56 μg/L in blood. This method was applied to the analysis of clinical samples and the concentrations of CN^– in the blood were as follows: 7.13 ± 2.41 μg/L for six healthy non-smokers, 3.08 ± 1.12 μg/L for six CO gas victims, 730 ± 867 μg for 21 house fire victims, and 3,030 ± 97 μg/L for a victim who ingested NaCN. The increase of CN^– in the blood of a victim who ingested NaN₃ was confirmed using MS-MS for the first time, and the concentrations of CN^– in the blood, gastric content and urine were 78.5 ± 5.5, 11.8 ± 0.5, and 11.4 ± 0.8 μg/L, respectively.     

Comparison of solid-phase and single-drop microextractions for headspace analysis of herbal essential oils

The analytical microextraction methods of gas chromatography coupled with flame ionisation detector (GC-FID) for determination of selected essential oils in herbs were proposed. Two microextraction methods for the isolation of essential oils from plants such as Lavandula spica L., Melissa officinalis L., Mentha piperita L. and Salvia officinalis L. were used. The methods of solid-phase and single-drop microextractions, were optimised and compared. The obtained LOD values for all studied essential oils were found to be within 2.5–20.5 μg for SDME and 57.0–139.8 μg for SPME method per 100 g of dried sample leaves. The appropriate LOQ values were then 8.4–68.4 μg for SDME and 189.8–466.1 μg for SPME of target analytes per 100 g of dried sample leaves.      

A Novel Enhancing Flow-Injection Chemiluminescence Method for the Determination of Glutathione Using the Reaction of Luminol with Hydrogen Peroxide

 A rapid flow-injection method with chemiluminescence (CL) detection is described for the determination of glutathione (GSH). The method is based on the CL reaction of luminol and hydrogen peroxide. GSH can greatly enhance the chemiluminescence intensity in 0.1 mol/L borax–sodium hydroxide buffer solution (pH = 9.7). The maximum CL intensity was directly proportional to the concentration of GSH in the range 3.0 × 10⁻⁷–2.0 × 10⁻⁵ mol/L, and the detection limit was 6.8 × 10⁻⁸ mol/L. The relative standard deviation was 3.4% for 5.0 × 10⁻⁶ mol/L of GSH (n = 11). Received October 23, 2001; accepted June 18, 2002     

Simple LC Method with Chemiluminescence Detection for Simultaneous Determination of Arbutin and l-Ascorbic Acid in Whitening Cosmetics

Simultaneous determination of arbutin (ART) and l-ascorbic acid (AA) by HPLC with chemiluminescence detection is proposed for the first time. This method is based on the CL reaction of acidic potassium permanganate with ART and AA in the presence of formaldehyde as enhancer. The separation was performed on a C₁₈ column with a 90:10 (v/v) mixture of 0.02 M phosphate buffer and methanol as mobile phase. The effects of several conditions on HPLC resolution and CL emission were studied systematically. The linear ranges were 0.5–50 and 1–200 μg mL⁻¹ for ART and AA, respectively. The detection limits were 0.2 and 0.3 μg mL⁻¹, respectively. The method was successfully applied to the determination of ART and AA in whitening cosmetics.     

Comparison of extraction techniques for gas chromatographic determination of volatile carbonyl compounds in alcohols

Two extraction procedures, i.e. conventional liquid-liquid extraction (LLE) and liquid solid-phase microextraction (SPME) for extraction of the oximes formed after derivatization of carbonyl compounds with o-(2,3, 4,5,6-pentafluorobenzyl) hydroxylamine (PFBHA) in alcoholic solutions have been compared. The limit of detection for LLE followed by GC-ECD determination of C₁–C₆ was in the range of 0.23–3.3 μg/L, whereas for liquid SPME 0.005–0.33 μg/L. Both methods elaborated can be applied to the determination of carbonyl compounds present in spirits and alcoholic beverages. Received: 26 September 2000 / Revised: 14 January 2001 / Accepted: 16 January 2001     

Determination of uranium and thorium in natural waters by ICP-OES after on-line solid phase extraction and preconcentration in the presence of 2,3-dihydro-9,10-dihydroxy-1,4-antracenedion

An on-line solid phase extraction method, linked to inductively coupled plasma optical emission spectrometry (ICP-OES), has been examined using octadecyl-bonded silica cartridge for determination of low levels of uranium and thorium in aqueous samples. 2,3-dihydro-9,10-dihydroxy-1,4-anthracenedion forms a hydrophobic complex with cations and the resulted complex was retained on SPE. The retained complex was eluted using an acidic solution and introduced into ICP for determination. Various effective parameters and chemical variables such as sample pH, amount of ligand (as a complexing agent), sampling and eluting flow rates and concentration of the eluent were optimized. Under optimal conditions, calibration curves with dynamic linear ranges of 1–200 μg/L (r ₂ = 0.9999) and 1–500 μg/L (r ₂ = 0.9994) for U and Th were obtained, respectively. Detection limits based on three times of standard deviations of blank by 6 replicates were 0.69 μg/L and 0.84 μg/L for U and Th, respectively. Sample throughput was 10 samples/h. The interference effects of several metal ions on percentage of recovery of U and Th were also studied. The method was applied to the recovery and sequential determination of these actinide elements in different water samples.     

On the certification of cadmium at trace and ultratrace levels in standard reference materials using ID ICP-MS

Analytical methods used for the isotope dilution inductively coupled plasma mass spectrometric (ID-ICP-MS) measurement of Cd at μg kg⁻¹ and sub-μg kg⁻¹ levels are described and applied to the certification of new dietary supplement, blood, and serum Standard Reference Materials (SRMs). The materials are: SRM 3240 Ephedra sinica Stapf Aerial Parts, SRM 3241 Ephedra sinica Stapf Native Extract, SRM 3243 Ephedra-Containing Solid Oral Dosage Form, SRM 3244 Ephedra-Containing Protein Powder, SRM 966 Toxic Metals in Bovine Blood, Level 1 (L1) and Level 2 (L2), and SRM 1598a Animal Serum. The concentration of Cd in the materials ranges from 120 μg kg⁻¹ down to 0.03 μg kg⁻¹. At these levels, the factors that most influence the accuracy of the ICP-MS data are the procedure blank and spectral and nonspectral interferences. Nonspectral interference, caused by the high concentration of dissolved solids in the matrices investigated, resulted in signal suppression. Matrix separation was used to enhance signal intensity and to reduce spectral interference for the accurate determination of Cd in SRM 1598a and SRM 3244. Chromatographic separation procedures using Chelex for SRM 1598a and anion exchange for SRM 3244 were optimized to achieve the desired separation characteristics without substantially increasing the procedure blank. Sensitivity for the determination of Cd in serum was additionally enhanced through the use of desolvation nebulization. We determined that separations were not required for the accurate ICP-MS determination of Cd in SRM 3240, SRM 3241, SRM 3243, and SRM 966 L2 under optimized analysis conditions. These samples were diluted to a minimum volume and introduced to the ICP-MS via low flow (40–100 μL/min) microconcentric nebulizers. SRM 966 L1 was also analyzed directly, but results were highly variable. The ID-ICP-MS sample preparation and ratio measurement protocols described here resulted in total expanded uncertainties of less than 1% for the determination of 90.85 μg kg⁻¹ Cd in SRM 3240, and less than 10% total expanded uncertainty for the determination of 0.0468 μg kg⁻¹ Cd in SRM 1598a.     

Flow-injection enhanced chemiluminescence method for determination of ciprofloxacin in pharmaceutical preparations and biological fluids

A novel rapid and sensitive analytical method, enhanced chemiluminescence with flow-injection sampling, is described for determination of ciprofloxacin. The method is based on the chemiluminescence reaction of the potassium permanganate–sodium thiosulfate–ciprofloxacin system. An enhanced chemiluminescence reaction was developed, and optimum conditions for CL emission were investigated. The chemiluminescence intensity was linearly dependent on ciprofloxacin concentration in the range 1.0×10⁻⁸–1.0×10⁻⁵ g mL⁻¹. The detection limit was 4×10⁻⁹ g mL⁻¹. The relative standard deviation was 1.8% for eleven measurements of 2.0×10⁻⁷ g mL⁻¹ ciprofloxacin standard solution. The new method enables simple, sensitive, and rapid determination of ciprofloxacin and has been successfully used for determination of ciprofloxacin in biological fluids and in ciprofloxacin hydrochloride tablet and injection.     

Determination of ascorbic acid by use of a flow-through solid phase UV spectrophotometric system

A continuous flow-through solid phase spectrophotometric system was developed for the determination of ascorbic acid based on the measurement of its intrinsic absorbance in the UV region when retained on a 1 mm Sephadex QAE A-25 anion exchanger gel layer which is placed into an appropriate quartz flow-through cell, the absorbance exhibited by this solid phase being monitored at 267 nm. A monochannel manifold was used, the sample (300, 600 or 1000 μL) being injected into the carrier solution (acetate buffer). This solution also elutes the analyte after developing the analytical signal, and regenerates the resin layer which, therefore, remains ready for the next sample. The linear dynamic range and other analytical parameters vary according to the sample volume injected. Three calibration lines were established for 300, 600 and 1000 μL sample volume, which ranged from 1.0 to 20.0, 0.5 to 10.0 and 0.2 to 6.0 μg mL^–1, respectively. The detection limits were 0.04 (300 μL), 0.03 (600 μL) and 0.02 μg mL^–1 (1000 μL), the sampling rates 28, 24 and 21 h^–1, and the RSDs (n = 10) 0.87%, 1.08% and 0.90%, respectively. The amount of ascorbic acid in various samples (pharmaceuticals, sweets and urine) were successfully determined with this method. Received: 28 April 1998 / Revised: 3 June 1998 / Accepted: 30 June 1998     

Determination of ascorbic acid by use of a flow-through solid phase UV spectrophotometric system

A continuous flow-through solid phase spectrophotometric system was developed for the determination of ascorbic acid based on the measurement of its intrinsic absorbance in the UV region when retained on a 1 mm Sephadex QAE A-25 anion exchanger gel layer which is placed into an appropriate quartz flow-through cell, the absorbance exhibited by this solid phase being monitored at 267 nm. A monochannel manifold was used, the sample (300, 600 or 1000 μL) being injected into the carrier solution (acetate buffer). This solution also elutes the analyte after developing the analytical signal, and regenerates the resin layer which, therefore, remains ready for the next sample. The linear dynamic range and other analytical parameters vary according to the sample volume injected. Three calibration lines were established for 300, 600 and 1000 μL sample volume, which ranged from 1.0 to 20.0, 0.5 to 10.0 and 0.2 to 6.0 μg mL^–1, respectively. The detection limits were 0.04 (300 μL), 0.03 (600 μL) and 0.02 μg mL^–1 (1000 μL), the sampling rates 28, 24 and 21 h^–1, and the RSDs (n = 10) 0.87%, 1.08% and 0.90%, respectively. The amount of ascorbic acid in various samples (pharmaceuticals, sweets and urine) were successfully determined with this method. Received: 28 April 1998 / Revised: 3 June 1998 / Accepted: 30 June 1998     

Determination of superoxide dismutase and SOD-mimetic activities by a chemical system: Co2/H2O2/lucigenin

The bright chemiluminescence has been observed in the system: Co²⁺/hydrogen peroxide/lucigenin. The chemiluminescence intensity was directly proportional to either cobalt, hydrogen peroxide, or lucigenin concentrations. A procedure of determination of superoxide dismutase (SOD) activity by the chemiluminescence method in the cobalt–hydrogen peroxide–lucigenin system at pH 8.5 is suggested. A linear dependence was established between a relative chemiluminescence intensity and SOD concentration in the range of SOD concentrations between 0 and 4.5 nM, c _1/2 = 0.8 nM. The determination of SOD activity was performed in several tissue samples (rat plasma, erythrocyte hemolysate, and liver mitochondria). A technique of tissue sample preparation with the use of thermal inactivation of interfering proteins at 60 °C was used. The method was successfully applied for comparison of the efficiency of SOD mimetics.     

Determination of imidacloprid in paddy water and soil by liquid chromatography electrospray ionization-tandem mass spectrometry

A method for the determination of imidacloprid in paddy water and soil was developed using liquid chromatography electrospray ionization-tandem mass spectrometry (LC/ESI-MS/MS). Separation of imidacloprid was carried out on a Shimadzu C18 column (150 mm × 4.6 mm, 4.6 μm) with an acetonitrile-water (50: 50, v/v) mobile phase containing 0.1% of acetic acid. The flow rate was 0.3 mL/min in isocratic mode. The product ion at 209 m/z was selected for quantification in multiple-reaction monitoring scan mode. Imidacloprid residues in soil were extracted by a solid-liquid extraction method with acetonitrile. Water samples were filtered and directly injected for analysis without extraction. Detection limits of 0.5 μg/kg and 0.3 μg/L were achieved for soil and water samples, respectively. The method had recoveries of 90 ± 2% (n = 4) for soil samples and 100 ± 2% (n = 4) for water samples. A linear relationship was observed throughout the investigated range of concentrations (1–200 μg/L), with the correlation coefficients ranging from 0.999 to 1.000.     

Accurate quantification of mercapturic acids of styrene (PHEMAs) in human urine with direct sample injection using automated column-switching high-performance liquid chromatography coupled with tandem mass spectrometry

Styrene is one of the most important industrial chemicals, with an enormously high production volume worldwide. The urinary mercapturic acids of its metabolite styrene-7,8-oxide, namely N-acetyl-S-(2-hydroxy-1-phenylethyl)-l-cysteine (PHEMA 1) and N-acetyl-S-(2-hydroxy-2-phenylethyl)-l-cysteine (PHEMA 2), are specific biomarkers for the determination of individual internal exposure to this highly reactive intermediate of styrene. We have developed and validated a fast, specific and very sensitive method for the accurate determination of the sum of phenylhydroxyethyl mercapturic acids (PHEMAs) in human urine with an automated multidimensional liquid chromatography–tandem mass spectrometry method using ¹³C₆-labelled PHEMAs as internal standards. Analytes were stripped from the urinary matrix by online extraction on a restricted access material, transferred to the analytical column and subsequently determined by tandem mass spectrometry. The limit of quantification (LOQ) for the sum of PHEMAs was 0.3 μg/L urine and allowed us to quantify the background exposure of the (smoking) general population. Precision within series and between series ranged from 1.5 to 6.8% at three concentrations ranging from 3 to 30 μg/L urine; the mean accuracy was between 104 and 110%. We applied the method to spot urine samples from 40 subjects of the general population with no known occupational exposure to styrene. The median levels (range) for the sum of PHEMAs in urine of non-smokers (n = 22) were less than 0.3 μg/L (less than 0.3 to 1.1 μg/L), whereas in urine of smokers (n = 18), the median levels were 0.46 μg/L (less than 0.3 to 2.8 μg/L). Smokers showed a significantly higher excretion of the sum of PHEMAs (p = 0.02). Owing to its automation and high sensitivity, our method is well suited for application in occupational or environmental studies.     

Determination of illicit and medicinal drugs and their metabolites in oral fluid and preserved oral fluid by liquid chromatography–tandem mass spectrometry

An LC-MS/MS method using 0.5 ml of oral fluid was developed for the determination of morphine, codeine, 6-monoacetylmorphine, methadone, amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxy-N-ethylamphetamine, benzoylecgonine, cocaine, delta-9-tetrahydrocannabinol, zolpidem, zopiclone, alprazolam, clonazepam, oxazepam, nordiazepam, lorazepam, flunitrazepam, diazepam, diphenhydramine and amitriptyline. The method was fully validated in terms of linearity (the method was linear between 1–5 μg/L and 100–200 μg/L) recoveries (7.5–82.6%), within-day and between-day precisions and accuracies (CV and MRE, both <15%), limits of detection (0.5 μ g/L) and quantitation (the lowest point on the calibration curve), relative ion intensities, freeze-and-thaw stability and matrix effect. The method was applied to preserved oral fluid collected by a special commercial device, the StatSure Saliva Sampler™.     

Isocratic Reversed-Phase HPLC for Simultaneous Separation and Determination of Seven Antiepileptic Drugs and Two of their Active Metabolites in Human Plasma

A simple reversed-phase high-performance liquid chromatographic (HPLC) method has been developed for the simultaneous determination of the antiepileptic drugs (AEDs) zonisamide (ZNS), primidone (PRI), lamotrigine (LTG), phenobarbital (PB), phenytoin (PHT), oxcarbazepine (OXC), and carbamazepine (CBZ) and two of their active metabolites, monohydroxycarbamazepine (MHD) and carbamazepine 10,11-epoxide (CBZE) in human plasma. Plasma (100 μL) was pretreated by deproteinization with 300 μL methanol containing 20 μg mL⁻¹ propranolol hydrochloride as internal standard. HPLC was performed on a C₈ column (4.6 mm × 250 mm; particle size 5 μm) with methanol–acetonitrile–0.1% trifluoroacetic acid, 235:120:645 (v/v), as mobile phase at a flow rate of 1.5 mL min⁻¹. ZNS, OXC, and CBZ were monitored by UV detection at 235 nm, and PRI, LTG, MHD, PB, PHT, and CBZE by UV detection at 215 nm. Relationships between response and concentration were linear over the concentration ranges 1–80 μg mL⁻¹ for ZNS, 5–50 μg mL⁻¹ for PRI, 1–25 μg mL⁻¹ for LTG, 1–50 μg mL⁻¹ for MHD, 5–100 μg mL⁻¹ for PB, 1–10 μg mL⁻¹ for CBZE, 0.5–25 μg mL⁻¹ for OXC, 1–50 μg mL⁻¹ for PHT, and 1–25 μg mL⁻¹ for CBZ. Intra-day and inter-day reproducibility were adequate (coefficients of variation were ≤11.6%) and absolute recovery ranged from 95.2 ± 6.13 to 107.7 ± 7.76% for all the analytes; for the IS recovery was 98.69 ± 1.12%. The method was proved to be accurate, reproducible, convenient, and suitable for therapeutic monitoring of the nine analytes.     

Determination of Trihalomethanes in Drinking Water by Dispersive Liquid–Liquid Microextraction then Gas Chromatography with Electron-Capture Detection

Dispersive liquid–liquid microextraction (DLLME) has been used for preconcentration of trihalomethanes (THMs) in drinking water. In DLLME an appropriate mixture of an extraction solvent (20.0 μL carbon disulfide) and a disperser solvent (0.50 mL acetone) was used to form a cloudy solution from a 5.00-mL aqueous sample containing the analytes. After phase separation by centrifugation the enriched analytes in the settled phase (6.5 ± 0.3 μL) were determined by gas chromatography with electron-capture detection (GC–ECD). Different experimental conditions, for example type and volume of extraction solvent, type and volume of disperser solvent, extraction time, and use of salt, were investigated. After optimization of the conditions the enrichment factor ranged from 116 to 355 and the limit of detection from 0.005 to 0.040 μg L⁻¹. The linear range was 0.01–50 μg L⁻¹ (more than three orders of magnitude). Relative standard deviations (RSDs) for 2.00 μg L⁻¹ THMs in water, with internal standard, were in the range 1.3–5.9% (n = 5); without internal standard they were in the range 3.7–8.6% (n = 5). The method was successfully used for extraction and determination of THMs in drinking water. The results showed that total concentrations of THMs in drinking water from two areas of Tehran, Iran, were approximately 10.9 and 14.1 μg L⁻¹. Relative recoveries from samples of drinking water spiked at levels of 2.00 and 5.00 μg L⁻¹ were 95.0–107.8 and 92.2–100.9%, respectively. Comparison of this method with other methods indicates DLLME is a very simple and rapid (less than 2 min) method which requires a small volume of sample (5 mL).     

Spectrophotometric determination of methimazole in pharmaceutical,serum and urine samples by reaction with potassium ferricyanide-Fe(III)

This paper describes a novel method to determine methimazole by spectrophotometry using a potassium ferricyanide-Fe(III) reaction. The study indicates that at pH 4.0 Fe(III) is reduced to Fe(II) by methimazole and in situ formed Fe(II) reacts with potassium ferricyanide to give soluble Prussian Blue which is characterized by means of XRD analysis. The absorbance of Prussian Blue is measured at the absorption maximum of 735 nm, and the amount of methimazole can be determined based on this absorbance. Beer’s law is obeyed in the range of methimazole concentrations of 0.02–6.00 μg/mL. The equation of the linear regression is A = −0.0058 + 0.49988c (μg/mL), with a correlation coefficient of 0.9998 and RSD of 0.80%. The detection limit (3σ/k) is 0.015 μg/mL, and the apparent molar absorption coefficient of indirect determination of methimazole is 5.7 ± 10⁴ L/mol cm. This method has been successfully applied to the determination of methimazole in pharmaceutical, serum and urine samples, and average recoveries are in the range of 98.6–102.4%. Analytical results obtained with this novel method are satisfactory.     

Determination of thorium and uranium in activated concrete by inductively coupled plasma mass spectrometry after anion-exchange separation

A sensitive analytical method was established for the determination of Th and U in activated concrete samples. The method combines an anion-exchange separation step with an ICP-MS determination technique. In the ICP-MS measurement, a few μg mL^–1 of Al and Ca, a few ng mL^–1 of Mn, La, Ce, Nd and Pb and pg mL^–1 amounts of Li, Zr, Nb and Ba coexisting in the anion-exchange fraction of Th and U did not interfere. No adverse interference effects were observed in real sample analyses. The obtained detection limits (3σ, n = 10) of Th and U were 2.3 and 1.8 pg mL^–1, respectively. The analytical precisions for ca. 5 μg g^–1 Th and ca. 1 μg g^–1 U in real activated concrete samples were equally less than 7% RSD. The accuracies obtained by the analysis of GSJ rock standard samples were –18.1 to 0.4% for the Th determination and –14.0 to –5.7% for the U determination. The method uses the conventional absolute calibration curve. The internal standard calibration is unnecessary. Received: 14 March 1999 / Revised: 13 July 1999 / Accepted: 15 July 1999     

Determination of hydrazine by liquid chromatography with preliminary derivatization with naphthalene-2,3-dialdehyde

A method is proposed for the quantification of hydrazine by reversed-phase chromatography after its derivatization with naphthalene-2,3-dialdehyde. The conditions of derivatization and the chromatography separation on a Zorbax Eclipse XDB-C8 column in the gradient mode are optimized. The derivatization and chromatography analysis take 1 and 16 min, respectively. If fluorimetry detection (λ_ex = 273 nm, λ_em = 500 nm) is used and the injection volume is 100 μL, the detection limit is 0.05 μg/L. The procedure is applicable to the quantification of hydrazine in natural waters and soil extracts. A simple and rapid procedure is elaborated for the determination of 0.1–50 μg/L hydrazine in natural waters, RSD = 12% (n = 3).